CG
LAB icon

Cutler Group’s Standard BioTools LAB Stock Holding History

Cutler Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30,700
Closed -$27K – 6048
2021
Q1 		$27K Buy
30,700
+24,900
+429% +$137K ﹤0.01% 2944
2020
Q4 		$6K Sell
5,800
-44,200
-88% -$290K ﹤0.01% 3533
2020
Q3 		$44K Buy
+50,000
New +$345K ﹤0.01% 1874
2017
Q3 		– Sell
-1,000
Closed -$1K – 6294
2017
Q2 		$1K Buy
+1,000
New +$4.74K ﹤0.01% 5915
2017
Q1 		– Sell
-5,200
Closed -$4K – 6817
2016
Q4 		$4K Buy
5,200
+700
+16% +$4.4K ﹤0.01% 5087
2016
Q3 		$2K Buy
+4,500
New +$41.3K ﹤0.01% 5724
2016
Q1 		– Sell
-30,500
Closed -$40K – 6841
2015
Q4 		$40K Buy
+30,500
New +$300K ﹤0.01% 2701

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cutler Group's LAB Position: Q2 2022 in Review

Cutler Group sold out of Standard BioTools (LAB) in Q2 2022, closing a stake of 1,446 shares — an estimated $5K sold.

Cutler Group first reported a position in LAB in Q4 2015 and held it in 14 quarters. The position peaked at $430K in Q3 2020. 86 funds tracked by Wall St. Rank hold LAB as of Q2 2022.

  • Cutler Group reported no remaining Standard BioTools position as of Q2 2022 after selling out during the quarter.
  • Cutler Group sold 1,446 Standard BioTools shares in Q2 2022, an estimated $5K.
  • Cutler Group first reported a position in Standard BioTools in Q4 2015 and held it in 14 quarters.
  • Cutler Group's Standard BioTools position peaked at $430K in Q3 2020.
  • 86 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.